Loading insider details...
Beta
Latest Form 4 (Sep 30, 2026): Conversion of 7,127,019 ADRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | ADARx Pharmaceuticals, Inc. (ADRX) | Conversion | 7,127,019 | n/a |
| Aug 11, 2026 | Braveheart Bio, Inc. (BRVE) | Conversion | 9,132,420 | n/a |
| Aug 7, 2026 | Braveheart Bio, Inc. (BRVE) | Grant/Award | 30,000 | n/a |
| Jun 12, 2026 | Upstream Bio, Inc. (UPB) | Grant/Award | 17,096 | n/a |
| Jun 12, 2025 | Upstream Bio, Inc. (UPB) | Grant/Award | 17,096 | n/a |
| Oct 17, 2024 | Upstream Bio, Inc. (UPB) | Conversion | 721,956 | n/a |
| Oct 15, 2024 | Upstream Bio, Inc. (UPB) | Grant/Award | 17,096 | n/a |
| May 20, 2024 | BiomX Inc. (PHGE) | In-the-Money Exercise | 9,280,408 | $2.26M |
| Mar 20, 2024 | BiomX Inc. (PHGE) | Purchase | 4,327 | n/a |
| Jun 29, 2023 | Adicet Bio, Inc. (ACET) | Purchase | 125,000 | $261.2K |